Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -26,447 | N/A | N/A |
| Depreciation Amortization | 62 | N/A | N/A |
| Accounts payable and accrued liabilities | 723 | N/A | N/A |
| Other Working Capital | 2,120 | N/A | N/A |
| Other Operating Activity | 1,503 | 0 | 0 |
| Operating Cash Flow | $-22,039 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -137 | N/A | N/A |
| Purchase Of Investment | -1,935 | N/A | N/A |
| Investing Cash Flow | $-2,072 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 145,205 | N/A | N/A |
| Other Financing Activity | -319 | 0 | 0 |
| Financing Cash Flow | $144,886 | $N/A | $N/A |
| Beginning Cash Position | 19,458 | N/A | N/A |
| End Cash Position | 140,233 | N/A | N/A |
| Net Cash Flow | $120,775 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -22,039 | N/A | N/A |
| Capital Expenditure | -137 | N/A | N/A |
| Free Cash Flow | -22,176 | 0 | 0 |